Rachman Ilya M's Form 4 filing
Immix Biopharma, Inc. (IMMX) · filed Nov 15, 2022
- Accession no.
- 0001493152-22-032557
- Filed
- Nov 15, 2022
- Trade date
- Nov 14, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $5.23K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rachman Ilya MCIK 0001889334 | Director, Officer (CEO and Chairman) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 | Common Stock | PPurchaseAcquired | +4,050 | $1.02 | +$4,131 | 906,550 | Direct | |
| Nov 14, 2022 | Common Stock | PPurchaseAcquired | +1,000 | $0.95 | +$950 | 907,550 | Direct | |
| Nov 14, 2022 | Common Stock | PPurchaseAcquired | +150 | $0.99 | +$148.5 | 907,700 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.